nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—epilepsy syndrome	0.265	1	CbGaD
Gatifloxacin—ALB—Oxcarbazepine—epilepsy syndrome	0.0999	0.205	CbGbCtD
Gatifloxacin—ALB—Fosphenytoin—epilepsy syndrome	0.0873	0.179	CbGbCtD
Gatifloxacin—ALB—Clonazepam—epilepsy syndrome	0.0789	0.162	CbGbCtD
Gatifloxacin—ALB—Rufinamide—epilepsy syndrome	0.0644	0.132	CbGbCtD
Gatifloxacin—ALB—Phenytoin—epilepsy syndrome	0.0562	0.116	CbGbCtD
Gatifloxacin—ALB—Propofol—epilepsy syndrome	0.0525	0.108	CbGbCtD
Gatifloxacin—ALB—Diazepam—epilepsy syndrome	0.0475	0.0976	CbGbCtD
Gatifloxacin—ALB—Transport of organic anions—SLCO1A2—epilepsy syndrome	0.00113	0.0776	CbGpPWpGaD
Gatifloxacin—ALB—Recycling of bile acids and salts—SLCO1A2—epilepsy syndrome	0.000834	0.0575	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A2—epilepsy syndrome	0.000551	0.038	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A3—epilepsy syndrome	0.000551	0.038	CbGpPWpGaD
Gatifloxacin—Sparfloxacin—ABCC2—epilepsy syndrome	0.000531	0.294	CrCbGaD
Gatifloxacin—Lomefloxacin—ABCC2—epilepsy syndrome	0.000437	0.242	CrCbGaD
Gatifloxacin—ALB—Bile acid and bile salt metabolism—SLCO1A2—epilepsy syndrome	0.000436	0.0301	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—SLCO1A2—epilepsy syndrome	0.000418	0.0288	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—FOLR1—epilepsy syndrome	0.000397	0.0274	CbGpPWpGaD
Gatifloxacin—ALB—Bile acid and bile salt metabolism—HSD17B4—epilepsy syndrome	0.000384	0.0265	CbGpPWpGaD
Gatifloxacin—Ofloxacin—ABCC2—epilepsy syndrome	0.000373	0.207	CrCbGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.000371	0.0256	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—epilepsy syndrome	0.000325	0.0224	CbGpPWpGaD
Gatifloxacin—ALB—Transport of organic anions—AVP—epilepsy syndrome	0.000324	0.0223	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—LAMP2—epilepsy syndrome	0.000278	0.0191	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—LAMP2—epilepsy syndrome	0.000265	0.0182	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.000257	0.0177	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000203	0.014	CbGpPWpGaD
Gatifloxacin—ALB—HDL-mediated lipid transport—APOE—epilepsy syndrome	0.000196	0.0135	CbGpPWpGaD
Gatifloxacin—Sparfloxacin—ABCB1—epilepsy syndrome	0.000195	0.108	CrCbGaD
Gatifloxacin—ALB—Platelet degranulation—FLNA—epilepsy syndrome	0.000139	0.00961	CbGpPWpGaD
Gatifloxacin—Levofloxacin—ABCB1—epilepsy syndrome	0.000137	0.0761	CrCbGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.000133	0.00917	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—FLNA—epilepsy syndrome	0.000133	0.00916	CbGpPWpGaD
Gatifloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000133	0.0735	CrCbGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—LAMP2—epilepsy syndrome	0.000123	0.00849	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—PLAT—epilepsy syndrome	0.000122	0.00842	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—epilepsy syndrome	0.00012	0.00828	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000118	0.00815	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000118	0.00815	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000118	0.00815	CbGpPWpGaD
Gatifloxacin—ALB—Lipoprotein metabolism—APOE—epilepsy syndrome	0.000112	0.00774	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—PPIA—epilepsy syndrome	0.00011	0.00756	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000108	0.00746	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PPIA—epilepsy syndrome	0.000105	0.0072	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—PLAT—epilepsy syndrome	9.94e-05	0.00685	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—epilepsy syndrome	9.3e-05	0.00641	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	8.97e-05	0.00618	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	8.97e-05	0.00618	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	8.97e-05	0.00618	CbGpPWpGaD
Gatifloxacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—epilepsy syndrome	8.75e-05	0.00603	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	8.55e-05	0.00589	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—PLAT—epilepsy syndrome	7.89e-05	0.00544	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—DOCK7—epilepsy syndrome	7.79e-05	0.00537	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—CAT—epilepsy syndrome	7.69e-05	0.0053	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—CRP—epilepsy syndrome	7.51e-05	0.00517	CbGpPWpGaD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	7.46e-05	0.00514	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—APOE—epilepsy syndrome	7.35e-05	0.00506	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	6.97e-05	0.00481	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—GPX1—epilepsy syndrome	6.96e-05	0.0048	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	6.79e-05	0.00468	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	6.79e-05	0.00468	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	6.74e-05	0.00465	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	6.74e-05	0.00465	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—LAMP2—epilepsy syndrome	6.35e-05	0.00438	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.32e-05	0.00436	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.32e-05	0.00436	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	6.21e-05	0.00428	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	6.19e-05	0.00426	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	6.18e-05	0.00426	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.11e-05	0.00421	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—CRP—epilepsy syndrome	6.11e-05	0.00421	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	6.01e-05	0.00414	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	6.01e-05	0.00414	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	6.01e-05	0.00414	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	5.78e-05	0.00398	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	5.53e-05	0.00381	CbGpPWpGaD
Gatifloxacin—Headache—Fosphenytoin—epilepsy syndrome	5.51e-05	0.000238	CcSEcCtD
Gatifloxacin—Hepatitis—Topiramate—epilepsy syndrome	5.51e-05	0.000238	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.5e-05	0.00379	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.5e-05	0.000238	CcSEcCtD
Gatifloxacin—Palpitations—Pregabalin—epilepsy syndrome	5.5e-05	0.000238	CcSEcCtD
Gatifloxacin—Asthenia—Phenytoin—epilepsy syndrome	5.5e-05	0.000238	CcSEcCtD
Gatifloxacin—Nausea—Midazolam—epilepsy syndrome	5.48e-05	0.000237	CcSEcCtD
Gatifloxacin—Hallucination—Topiramate—epilepsy syndrome	5.48e-05	0.000237	CcSEcCtD
Gatifloxacin—Muscle spasms—Gabapentin—epilepsy syndrome	5.48e-05	0.000237	CcSEcCtD
Gatifloxacin—Tachycardia—Valproic Acid—epilepsy syndrome	5.48e-05	0.000237	CcSEcCtD
Gatifloxacin—Diarrhoea—Zonisamide—epilepsy syndrome	5.47e-05	0.000237	CcSEcCtD
Gatifloxacin—Pharyngitis—Topiramate—epilepsy syndrome	5.47e-05	0.000236	CcSEcCtD
Gatifloxacin—Loss of consciousness—Pregabalin—epilepsy syndrome	5.47e-05	0.000236	CcSEcCtD
Gatifloxacin—Asthenia—Oxcarbazepine—epilepsy syndrome	5.47e-05	0.000236	CcSEcCtD
Gatifloxacin—Pruritus—Clonazepam—epilepsy syndrome	5.46e-05	0.000236	CcSEcCtD
Gatifloxacin—Vomiting—Vigabatrin—epilepsy syndrome	5.45e-05	0.000236	CcSEcCtD
Gatifloxacin—Oedema peripheral—Topiramate—epilepsy syndrome	5.43e-05	0.000235	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.43e-05	0.000235	CcSEcCtD
Gatifloxacin—Pruritus—Phenytoin—epilepsy syndrome	5.42e-05	0.000234	CcSEcCtD
Gatifloxacin—Nausea—Levetiracetam—epilepsy syndrome	5.42e-05	0.000234	CcSEcCtD
Gatifloxacin—Rash—Vigabatrin—epilepsy syndrome	5.41e-05	0.000234	CcSEcCtD
Gatifloxacin—Dizziness—Felbamate—epilepsy syndrome	5.4e-05	0.000234	CcSEcCtD
Gatifloxacin—Dermatitis—Vigabatrin—epilepsy syndrome	5.4e-05	0.000234	CcSEcCtD
Gatifloxacin—Pruritus—Oxcarbazepine—epilepsy syndrome	5.39e-05	0.000233	CcSEcCtD
Gatifloxacin—Convulsion—Pregabalin—epilepsy syndrome	5.39e-05	0.000233	CcSEcCtD
Gatifloxacin—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.39e-05	0.000233	CcSEcCtD
Gatifloxacin—Vision blurred—Gabapentin—epilepsy syndrome	5.37e-05	0.000232	CcSEcCtD
Gatifloxacin—Headache—Vigabatrin—epilepsy syndrome	5.37e-05	0.000232	CcSEcCtD
Gatifloxacin—Hypertension—Pregabalin—epilepsy syndrome	5.37e-05	0.000232	CcSEcCtD
Gatifloxacin—Vomiting—Diazepam—epilepsy syndrome	5.37e-05	0.000232	CcSEcCtD
Gatifloxacin—Anorexia—Valproic Acid—epilepsy syndrome	5.35e-05	0.000231	CcSEcCtD
Gatifloxacin—Tremor—Gabapentin—epilepsy syndrome	5.34e-05	0.000231	CcSEcCtD
Gatifloxacin—Rash—Diazepam—epilepsy syndrome	5.32e-05	0.00023	CcSEcCtD
Gatifloxacin—Dermatitis—Diazepam—epilepsy syndrome	5.32e-05	0.00023	CcSEcCtD
Gatifloxacin—Visual impairment—Topiramate—epilepsy syndrome	5.31e-05	0.00023	CcSEcCtD
Gatifloxacin—Chest pain—Pregabalin—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Gatifloxacin—Myalgia—Pregabalin—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Gatifloxacin—Arthralgia—Pregabalin—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Gatifloxacin—Dizziness—Zonisamide—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Gatifloxacin—Headache—Diazepam—epilepsy syndrome	5.29e-05	0.000229	CcSEcCtD
Gatifloxacin—Anxiety—Pregabalin—epilepsy syndrome	5.28e-05	0.000228	CcSEcCtD
Gatifloxacin—Diarrhoea—Clonazepam—epilepsy syndrome	5.28e-05	0.000228	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SLC8A2—epilepsy syndrome	5.26e-05	0.00363	CbGpPWpGaD
Gatifloxacin—Hypotension—Valproic Acid—epilepsy syndrome	5.25e-05	0.000227	CcSEcCtD
Gatifloxacin—Asthenia—Carbamazepine—epilepsy syndrome	5.25e-05	0.000227	CcSEcCtD
Gatifloxacin—Agitation—Gabapentin—epilepsy syndrome	5.24e-05	0.000227	CcSEcCtD
Gatifloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	5.24e-05	0.000227	CcSEcCtD
Gatifloxacin—Nausea—Fosphenytoin—epilepsy syndrome	5.23e-05	0.000226	CcSEcCtD
Gatifloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.000225	CcSEcCtD
Gatifloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	5.21e-05	0.000225	CcSEcCtD
Gatifloxacin—Angioedema—Gabapentin—epilepsy syndrome	5.21e-05	0.000225	CcSEcCtD
Gatifloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.21e-05	0.000225	CcSEcCtD
Gatifloxacin—Vomiting—Felbamate—epilepsy syndrome	5.2e-05	0.000225	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	5.18e-05	0.00357	CbGpPWpGaD
Gatifloxacin—Pruritus—Carbamazepine—epilepsy syndrome	5.17e-05	0.000224	CcSEcCtD
Gatifloxacin—Rash—Felbamate—epilepsy syndrome	5.15e-05	0.000223	CcSEcCtD
Gatifloxacin—Eye disorder—Topiramate—epilepsy syndrome	5.15e-05	0.000223	CcSEcCtD
Gatifloxacin—Dermatitis—Felbamate—epilepsy syndrome	5.15e-05	0.000223	CcSEcCtD
Gatifloxacin—Tinnitus—Topiramate—epilepsy syndrome	5.14e-05	0.000222	CcSEcCtD
Gatifloxacin—Vertigo—Gabapentin—epilepsy syndrome	5.12e-05	0.000221	CcSEcCtD
Gatifloxacin—Headache—Felbamate—epilepsy syndrome	5.12e-05	0.000221	CcSEcCtD
Gatifloxacin—Confusional state—Pregabalin—epilepsy syndrome	5.12e-05	0.000221	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.12e-05	0.000221	CcSEcCtD
Gatifloxacin—Syncope—Gabapentin—epilepsy syndrome	5.11e-05	0.000221	CcSEcCtD
Gatifloxacin—Dizziness—Clonazepam—epilepsy syndrome	5.1e-05	0.00022	CcSEcCtD
Gatifloxacin—Nausea—Vigabatrin—epilepsy syndrome	5.1e-05	0.00022	CcSEcCtD
Gatifloxacin—Vomiting—Zonisamide—epilepsy syndrome	5.09e-05	0.00022	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.09e-05	0.00351	CbGpPWpGaD
Gatifloxacin—Insomnia—Valproic Acid—epilepsy syndrome	5.08e-05	0.00022	CcSEcCtD
Gatifloxacin—Oedema—Pregabalin—epilepsy syndrome	5.08e-05	0.000219	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.08e-05	0.000219	CcSEcCtD
Gatifloxacin—Asthenia—Lamotrigine—epilepsy syndrome	5.07e-05	0.000219	CcSEcCtD
Gatifloxacin—Dizziness—Phenytoin—epilepsy syndrome	5.06e-05	0.000219	CcSEcCtD
Gatifloxacin—Rash—Zonisamide—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—Infection—Pregabalin—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—Palpitations—Gabapentin—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—Dermatitis—Zonisamide—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	5.04e-05	0.000218	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—CCL2—epilepsy syndrome	5.02e-05	0.00346	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SLC8A3—epilepsy syndrome	5.02e-05	0.00346	CbGpPWpGaD
Gatifloxacin—Nausea—Diazepam—epilepsy syndrome	5.02e-05	0.000217	CcSEcCtD
Gatifloxacin—Loss of consciousness—Gabapentin—epilepsy syndrome	5.01e-05	0.000217	CcSEcCtD
Gatifloxacin—Headache—Zonisamide—epilepsy syndrome	5.01e-05	0.000217	CcSEcCtD
Gatifloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	5.01e-05	0.000216	CcSEcCtD
Gatifloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	5e-05	0.000216	CcSEcCtD
Gatifloxacin—Pruritus—Lamotrigine—epilepsy syndrome	5e-05	0.000216	CcSEcCtD
Gatifloxacin—Shock—Pregabalin—epilepsy syndrome	4.99e-05	0.000216	CcSEcCtD
Gatifloxacin—Somnolence—Valproic Acid—epilepsy syndrome	4.99e-05	0.000216	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.97e-05	0.000215	CcSEcCtD
Gatifloxacin—Tachycardia—Pregabalin—epilepsy syndrome	4.95e-05	0.000214	CcSEcCtD
Gatifloxacin—Chills—Topiramate—epilepsy syndrome	4.95e-05	0.000214	CcSEcCtD
Gatifloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	4.94e-05	0.000214	CcSEcCtD
Gatifloxacin—Convulsion—Gabapentin—epilepsy syndrome	4.94e-05	0.000214	CcSEcCtD
Gatifloxacin—Hypertension—Gabapentin—epilepsy syndrome	4.92e-05	0.000213	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	4.91e-05	0.00339	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.91e-05	0.000212	CcSEcCtD
Gatifloxacin—Vomiting—Clonazepam—epilepsy syndrome	4.9e-05	0.000212	CcSEcCtD
Gatifloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	4.88e-05	0.000211	CcSEcCtD
Gatifloxacin—Vomiting—Phenytoin—epilepsy syndrome	4.87e-05	0.00021	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	4.87e-05	0.00335	CbGpPWpGaD
Gatifloxacin—Rash—Clonazepam—epilepsy syndrome	4.86e-05	0.00021	CcSEcCtD
Gatifloxacin—Dermatitis—Clonazepam—epilepsy syndrome	4.86e-05	0.00021	CcSEcCtD
Gatifloxacin—Arthralgia—Gabapentin—epilepsy syndrome	4.86e-05	0.00021	CcSEcCtD
Gatifloxacin—Myalgia—Gabapentin—epilepsy syndrome	4.86e-05	0.00021	CcSEcCtD
Gatifloxacin—Chest pain—Gabapentin—epilepsy syndrome	4.86e-05	0.00021	CcSEcCtD
Gatifloxacin—Nausea—Felbamate—epilepsy syndrome	4.85e-05	0.00021	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	4.85e-05	0.00334	CbGpPWpGaD
Gatifloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000209	CcSEcCtD
Gatifloxacin—Anxiety—Gabapentin—epilepsy syndrome	4.84e-05	0.000209	CcSEcCtD
Gatifloxacin—Anorexia—Pregabalin—epilepsy syndrome	4.84e-05	0.000209	CcSEcCtD
Gatifloxacin—Dizziness—Carbamazepine—epilepsy syndrome	4.83e-05	0.000209	CcSEcCtD
Gatifloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	4.83e-05	0.000209	CcSEcCtD
Gatifloxacin—Headache—Clonazepam—epilepsy syndrome	4.83e-05	0.000209	CcSEcCtD
Gatifloxacin—Rash—Phenytoin—epilepsy syndrome	4.83e-05	0.000209	CcSEcCtD
Gatifloxacin—Dermatitis—Phenytoin—epilepsy syndrome	4.82e-05	0.000209	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	4.81e-05	0.00331	CbGpPWpGaD
Gatifloxacin—Rash—Oxcarbazepine—epilepsy syndrome	4.8e-05	0.000208	CcSEcCtD
Gatifloxacin—Constipation—Valproic Acid—epilepsy syndrome	4.8e-05	0.000208	CcSEcCtD
Gatifloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.8e-05	0.000207	CcSEcCtD
Gatifloxacin—Headache—Phenytoin—epilepsy syndrome	4.8e-05	0.000207	CcSEcCtD
Gatifloxacin—Erythema—Topiramate—epilepsy syndrome	4.8e-05	0.000207	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.79e-05	0.0033	CbGpPWpGaD
Gatifloxacin—Headache—Oxcarbazepine—epilepsy syndrome	4.77e-05	0.000206	CcSEcCtD
Gatifloxacin—Nausea—Zonisamide—epilepsy syndrome	4.75e-05	0.000205	CcSEcCtD
Gatifloxacin—Hypotension—Pregabalin—epilepsy syndrome	4.74e-05	0.000205	CcSEcCtD
Gatifloxacin—Flatulence—Topiramate—epilepsy syndrome	4.73e-05	0.000204	CcSEcCtD
Gatifloxacin—Tension—Topiramate—epilepsy syndrome	4.71e-05	0.000204	CcSEcCtD
Gatifloxacin—Dysgeusia—Topiramate—epilepsy syndrome	4.7e-05	0.000203	CcSEcCtD
Gatifloxacin—Confusional state—Gabapentin—epilepsy syndrome	4.69e-05	0.000203	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	4.68e-05	0.00323	CbGpPWpGaD
Gatifloxacin—Dizziness—Lamotrigine—epilepsy syndrome	4.67e-05	0.000202	CcSEcCtD
Gatifloxacin—Nervousness—Topiramate—epilepsy syndrome	4.66e-05	0.000201	CcSEcCtD
Gatifloxacin—Oedema—Gabapentin—epilepsy syndrome	4.65e-05	0.000201	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.65e-05	0.000201	CcSEcCtD
Gatifloxacin—Vomiting—Carbamazepine—epilepsy syndrome	4.65e-05	0.000201	CcSEcCtD
Gatifloxacin—Back pain—Topiramate—epilepsy syndrome	4.64e-05	0.000201	CcSEcCtD
Gatifloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.63e-05	0.0002	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.62e-05	0.0002	CcSEcCtD
Gatifloxacin—Infection—Gabapentin—epilepsy syndrome	4.62e-05	0.0002	CcSEcCtD
Gatifloxacin—Muscle spasms—Topiramate—epilepsy syndrome	4.61e-05	0.000199	CcSEcCtD
Gatifloxacin—Rash—Carbamazepine—epilepsy syndrome	4.61e-05	0.000199	CcSEcCtD
Gatifloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	4.61e-05	0.000199	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	4.6e-05	0.00317	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.59e-05	0.000198	CcSEcCtD
Gatifloxacin—Insomnia—Pregabalin—epilepsy syndrome	4.59e-05	0.000198	CcSEcCtD
Gatifloxacin—Nausea—Clonazepam—epilepsy syndrome	4.58e-05	0.000198	CcSEcCtD
Gatifloxacin—Headache—Carbamazepine—epilepsy syndrome	4.58e-05	0.000198	CcSEcCtD
Gatifloxacin—Shock—Gabapentin—epilepsy syndrome	4.58e-05	0.000198	CcSEcCtD
Gatifloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	4.56e-05	0.000197	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.56e-05	0.000197	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.56e-05	0.00314	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.56e-05	0.00314	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.56e-05	0.00314	CbGpPWpGaD
Gatifloxacin—Nausea—Phenytoin—epilepsy syndrome	4.55e-05	0.000197	CcSEcCtD
Gatifloxacin—Tachycardia—Gabapentin—epilepsy syndrome	4.54e-05	0.000196	CcSEcCtD
Gatifloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	4.53e-05	0.000196	CcSEcCtD
Gatifloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000196	CcSEcCtD
Gatifloxacin—Vision blurred—Topiramate—epilepsy syndrome	4.52e-05	0.000195	CcSEcCtD
Gatifloxacin—Somnolence—Pregabalin—epilepsy syndrome	4.51e-05	0.000195	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.5e-05	0.000194	CcSEcCtD
Gatifloxacin—Tremor—Topiramate—epilepsy syndrome	4.5e-05	0.000194	CcSEcCtD
Gatifloxacin—Vomiting—Lamotrigine—epilepsy syndrome	4.49e-05	0.000194	CcSEcCtD
Gatifloxacin—Urticaria—Valproic Acid—epilepsy syndrome	4.46e-05	0.000193	CcSEcCtD
Gatifloxacin—Rash—Lamotrigine—epilepsy syndrome	4.45e-05	0.000193	CcSEcCtD
Gatifloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	4.45e-05	0.000192	CcSEcCtD
Gatifloxacin—Body temperature increased—Valproic Acid—epilepsy syndrome	4.44e-05	0.000192	CcSEcCtD
Gatifloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	4.44e-05	0.000192	CcSEcCtD
Gatifloxacin—Anorexia—Gabapentin—epilepsy syndrome	4.44e-05	0.000192	CcSEcCtD
Gatifloxacin—Headache—Lamotrigine—epilepsy syndrome	4.43e-05	0.000191	CcSEcCtD
Gatifloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	4.41e-05	0.000191	CcSEcCtD
Gatifloxacin—Agitation—Topiramate—epilepsy syndrome	4.41e-05	0.000191	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.38e-05	0.00302	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	4.38e-05	0.00302	CbGpPWpGaD
Gatifloxacin—Hypotension—Gabapentin—epilepsy syndrome	4.35e-05	0.000188	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.35e-05	0.003	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.35e-05	0.003	CbGpPWpGaD
Gatifloxacin—Nausea—Carbamazepine—epilepsy syndrome	4.34e-05	0.000188	CcSEcCtD
Gatifloxacin—Constipation—Pregabalin—epilepsy syndrome	4.34e-05	0.000188	CcSEcCtD
Gatifloxacin—Vertigo—Topiramate—epilepsy syndrome	4.31e-05	0.000186	CcSEcCtD
Gatifloxacin—Syncope—Topiramate—epilepsy syndrome	4.3e-05	0.000186	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.24e-05	0.000183	CcSEcCtD
Gatifloxacin—Palpitations—Topiramate—epilepsy syndrome	4.24e-05	0.000183	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.22e-05	0.00291	CbGpPWpGaD
Gatifloxacin—Loss of consciousness—Topiramate—epilepsy syndrome	4.22e-05	0.000182	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—RELA—epilepsy syndrome	4.22e-05	0.00291	CbGpPWpGaD
Gatifloxacin—Insomnia—Gabapentin—epilepsy syndrome	4.21e-05	0.000182	CcSEcCtD
Gatifloxacin—Nausea—Lamotrigine—epilepsy syndrome	4.2e-05	0.000181	CcSEcCtD
Gatifloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	4.18e-05	0.000181	CcSEcCtD
Gatifloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	4.18e-05	0.000181	CcSEcCtD
Gatifloxacin—Convulsion—Topiramate—epilepsy syndrome	4.16e-05	0.00018	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.15e-05	0.000179	CcSEcCtD
Gatifloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	4.15e-05	0.000179	CcSEcCtD
Gatifloxacin—Hypertension—Topiramate—epilepsy syndrome	4.14e-05	0.000179	CcSEcCtD
Gatifloxacin—Somnolence—Gabapentin—epilepsy syndrome	4.14e-05	0.000179	CcSEcCtD
Gatifloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.14e-05	0.000179	CcSEcCtD
Gatifloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	4.1e-05	0.000177	CcSEcCtD
Gatifloxacin—Myalgia—Topiramate—epilepsy syndrome	4.08e-05	0.000177	CcSEcCtD
Gatifloxacin—Chest pain—Topiramate—epilepsy syndrome	4.08e-05	0.000177	CcSEcCtD
Gatifloxacin—Arthralgia—Topiramate—epilepsy syndrome	4.08e-05	0.000177	CcSEcCtD
Gatifloxacin—Anxiety—Topiramate—epilepsy syndrome	4.07e-05	0.000176	CcSEcCtD
Gatifloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	4.05e-05	0.000175	CcSEcCtD
Gatifloxacin—Urticaria—Pregabalin—epilepsy syndrome	4.03e-05	0.000174	CcSEcCtD
Gatifloxacin—Asthenia—Valproic Acid—epilepsy syndrome	4.03e-05	0.000174	CcSEcCtD
Gatifloxacin—Body temperature increased—Pregabalin—epilepsy syndrome	4.01e-05	0.000173	CcSEcCtD
Gatifloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	4.01e-05	0.000173	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	3.99e-05	0.00275	CbGpPWpGaD
Gatifloxacin—Constipation—Gabapentin—epilepsy syndrome	3.98e-05	0.000172	CcSEcCtD
Gatifloxacin—Pruritus—Valproic Acid—epilepsy syndrome	3.97e-05	0.000172	CcSEcCtD
Gatifloxacin—Confusional state—Topiramate—epilepsy syndrome	3.95e-05	0.000171	CcSEcCtD
Gatifloxacin—Oedema—Topiramate—epilepsy syndrome	3.92e-05	0.000169	CcSEcCtD
Gatifloxacin—Infection—Topiramate—epilepsy syndrome	3.89e-05	0.000168	CcSEcCtD
Gatifloxacin—Shock—Topiramate—epilepsy syndrome	3.85e-05	0.000167	CcSEcCtD
Gatifloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	3.84e-05	0.000166	CcSEcCtD
Gatifloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	3.84e-05	0.000166	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	3.83e-05	0.000166	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.83e-05	0.00264	CbGpPWpGaD
Gatifloxacin—Tachycardia—Topiramate—epilepsy syndrome	3.82e-05	0.000165	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IL1B—epilepsy syndrome	3.81e-05	0.00263	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.81e-05	0.000165	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	3.79e-05	0.00262	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	3.79e-05	0.000164	CcSEcCtD
Gatifloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	3.74e-05	0.000162	CcSEcCtD
Gatifloxacin—Anorexia—Topiramate—epilepsy syndrome	3.73e-05	0.000161	CcSEcCtD
Gatifloxacin—ALB—Metabolism—CA13—epilepsy syndrome	3.72e-05	0.00256	CbGpPWpGaD
Gatifloxacin—Dizziness—Valproic Acid—epilepsy syndrome	3.71e-05	0.00016	CcSEcCtD
Gatifloxacin—Urticaria—Gabapentin—epilepsy syndrome	3.7e-05	0.00016	CcSEcCtD
Gatifloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	3.68e-05	0.000159	CcSEcCtD
Gatifloxacin—Body temperature increased—Gabapentin—epilepsy syndrome	3.68e-05	0.000159	CcSEcCtD
Gatifloxacin—Hypotension—Topiramate—epilepsy syndrome	3.66e-05	0.000158	CcSEcCtD
Gatifloxacin—Asthenia—Pregabalin—epilepsy syndrome	3.64e-05	0.000157	CcSEcCtD
Gatifloxacin—Pruritus—Pregabalin—epilepsy syndrome	3.59e-05	0.000155	CcSEcCtD
Gatifloxacin—Vomiting—Valproic Acid—epilepsy syndrome	3.57e-05	0.000154	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.57e-05	0.000154	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.54e-05	0.00244	CbGpPWpGaD
Gatifloxacin—Insomnia—Topiramate—epilepsy syndrome	3.54e-05	0.000153	CcSEcCtD
Gatifloxacin—Rash—Valproic Acid—epilepsy syndrome	3.54e-05	0.000153	CcSEcCtD
Gatifloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	3.54e-05	0.000153	CcSEcCtD
Gatifloxacin—Headache—Valproic Acid—epilepsy syndrome	3.52e-05	0.000152	CcSEcCtD
Gatifloxacin—Paraesthesia—Topiramate—epilepsy syndrome	3.52e-05	0.000152	CcSEcCtD
Gatifloxacin—Dyspnoea—Topiramate—epilepsy syndrome	3.49e-05	0.000151	CcSEcCtD
Gatifloxacin—Somnolence—Topiramate—epilepsy syndrome	3.48e-05	0.00015	CcSEcCtD
Gatifloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	3.47e-05	0.00015	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.45e-05	0.00238	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.45e-05	0.00238	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Topiramate—epilepsy syndrome	3.45e-05	0.000149	CcSEcCtD
Gatifloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	3.43e-05	0.000148	CcSEcCtD
Gatifloxacin—Decreased appetite—Topiramate—epilepsy syndrome	3.4e-05	0.000147	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.4e-05	0.00234	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TEK—epilepsy syndrome	3.39e-05	0.00234	CbGpPWpGaD
Gatifloxacin—Dizziness—Pregabalin—epilepsy syndrome	3.36e-05	0.000145	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.35e-05	0.00231	CbGpPWpGaD
Gatifloxacin—Constipation—Topiramate—epilepsy syndrome	3.35e-05	0.000145	CcSEcCtD
Gatifloxacin—Asthenia—Gabapentin—epilepsy syndrome	3.34e-05	0.000144	CcSEcCtD
Gatifloxacin—Nausea—Valproic Acid—epilepsy syndrome	3.33e-05	0.000144	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.33e-05	0.00229	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.29e-05	0.00227	CbGpPWpGaD
Gatifloxacin—Pruritus—Gabapentin—epilepsy syndrome	3.29e-05	0.000142	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	3.25e-05	0.00224	CbGpPWpGaD
Gatifloxacin—Vomiting—Pregabalin—epilepsy syndrome	3.23e-05	0.00014	CcSEcCtD
Gatifloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	3.23e-05	0.000139	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.2e-05	0.000138	CcSEcCtD
Gatifloxacin—Rash—Pregabalin—epilepsy syndrome	3.2e-05	0.000138	CcSEcCtD
Gatifloxacin—Dermatitis—Pregabalin—epilepsy syndrome	3.2e-05	0.000138	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—FLNA—epilepsy syndrome	3.19e-05	0.0022	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	3.18e-05	0.000138	CcSEcCtD
Gatifloxacin—Headache—Pregabalin—epilepsy syndrome	3.18e-05	0.000137	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.17e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.16e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.16e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.16e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.16e-05	0.00218	CbGpPWpGaD
Gatifloxacin—Urticaria—Topiramate—epilepsy syndrome	3.11e-05	0.000134	CcSEcCtD
Gatifloxacin—Body temperature increased—Topiramate—epilepsy syndrome	3.1e-05	0.000134	CcSEcCtD
Gatifloxacin—Abdominal pain—Topiramate—epilepsy syndrome	3.1e-05	0.000134	CcSEcCtD
Gatifloxacin—Dizziness—Gabapentin—epilepsy syndrome	3.08e-05	0.000133	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3.04e-05	0.00209	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.03e-05	0.00209	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KCNMA1—epilepsy syndrome	3.02e-05	0.00208	CbGpPWpGaD
Gatifloxacin—Nausea—Pregabalin—epilepsy syndrome	3.02e-05	0.00013	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.99e-05	0.00206	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SLC8A1—epilepsy syndrome	2.99e-05	0.00206	CbGpPWpGaD
Gatifloxacin—Vomiting—Gabapentin—epilepsy syndrome	2.96e-05	0.000128	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.94e-05	0.00202	CbGpPWpGaD
Gatifloxacin—Rash—Gabapentin—epilepsy syndrome	2.93e-05	0.000127	CcSEcCtD
Gatifloxacin—Dermatitis—Gabapentin—epilepsy syndrome	2.93e-05	0.000127	CcSEcCtD
Gatifloxacin—Headache—Gabapentin—epilepsy syndrome	2.92e-05	0.000126	CcSEcCtD
Gatifloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	2.89e-05	0.000125	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	2.85e-05	0.00196	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADK—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—L2HGDH—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GLUD1—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CERS1—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PDXK—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FAR1—epilepsy syndrome	2.82e-05	0.00194	CbGpPWpGaD
Gatifloxacin—Asthenia—Topiramate—epilepsy syndrome	2.81e-05	0.000121	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.8e-05	0.00193	CbGpPWpGaD
Gatifloxacin—Pruritus—Topiramate—epilepsy syndrome	2.77e-05	0.00012	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	2.77e-05	0.00191	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—epilepsy syndrome	2.77e-05	0.00191	CbGpPWpGaD
Gatifloxacin—Nausea—Gabapentin—epilepsy syndrome	2.76e-05	0.00012	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.76e-05	0.0019	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.7e-05	0.00186	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.69e-05	0.00185	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Topiramate—epilepsy syndrome	2.68e-05	0.000116	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.64e-05	0.00182	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.6e-05	0.00179	CbGpPWpGaD
Gatifloxacin—Dizziness—Topiramate—epilepsy syndrome	2.59e-05	0.000112	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.58e-05	0.00178	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.58e-05	0.00178	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GAMT—epilepsy syndrome	2.58e-05	0.00177	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.58e-05	0.00177	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—EPM2A—epilepsy syndrome	2.58e-05	0.00177	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PNPO—epilepsy syndrome	2.58e-05	0.00177	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PPIA—epilepsy syndrome	2.51e-05	0.00173	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.5e-05	0.00172	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.5e-05	0.00172	CbGpPWpGaD
Gatifloxacin—Vomiting—Topiramate—epilepsy syndrome	2.49e-05	0.000108	CcSEcCtD
Gatifloxacin—Rash—Topiramate—epilepsy syndrome	2.47e-05	0.000107	CcSEcCtD
Gatifloxacin—Dermatitis—Topiramate—epilepsy syndrome	2.47e-05	0.000107	CcSEcCtD
Gatifloxacin—Headache—Topiramate—epilepsy syndrome	2.45e-05	0.000106	CcSEcCtD
Gatifloxacin—ALB—Metabolism—QDPR—epilepsy syndrome	2.39e-05	0.00165	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CA4—epilepsy syndrome	2.39e-05	0.00165	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.39e-05	0.00165	CbGpPWpGaD
Gatifloxacin—Nausea—Topiramate—epilepsy syndrome	2.33e-05	0.000101	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.29e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—COX3—epilepsy syndrome	2.25e-05	0.00155	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.22e-05	0.00153	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.22e-05	0.00153	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.2e-05	0.00151	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.14e-05	0.00148	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PFKL—epilepsy syndrome	2.13e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.13e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—KCNB1—epilepsy syndrome	2.13e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.13e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.13e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.09e-05	0.00144	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.07e-05	0.00143	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.03e-05	0.0014	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.98e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.96e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NEU1—epilepsy syndrome	1.95e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ATIC—epilepsy syndrome	1.95e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UPB1—epilepsy syndrome	1.95e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAT—epilepsy syndrome	1.95e-05	0.00134	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.88e-05	0.00129	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS1—epilepsy syndrome	1.83e-05	0.00126	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GBE1—epilepsy syndrome	1.81e-05	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.81e-05	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.77e-05	0.00122	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT3—epilepsy syndrome	1.71e-05	0.00118	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ASAH1—epilepsy syndrome	1.71e-05	0.00118	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.69e-05	0.00117	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.69e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—STXBP1—epilepsy syndrome	1.66e-05	0.00114	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NT5E—epilepsy syndrome	1.62e-05	0.00111	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALAD—epilepsy syndrome	1.62e-05	0.00111	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.61e-05	0.00111	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CDC42—epilepsy syndrome	1.56e-05	0.00108	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.54e-05	0.00106	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.54e-05	0.00106	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.51e-05	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADSL—epilepsy syndrome	1.48e-05	0.00102	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GLUL—epilepsy syndrome	1.45e-05	0.001	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.42e-05	0.000981	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FYN—epilepsy syndrome	1.39e-05	0.00096	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.34e-05	0.000923	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.33e-05	0.000918	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.32e-05	0.000912	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.31e-05	0.000904	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AQP1—epilepsy syndrome	1.29e-05	0.000891	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.27e-05	0.000875	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.26e-05	0.000868	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.24e-05	0.000856	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.23e-05	0.000846	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAU—epilepsy syndrome	1.19e-05	0.000819	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CHRM3—epilepsy syndrome	1.17e-05	0.000806	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.17e-05	0.000806	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.11e-05	0.000762	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS2—epilepsy syndrome	1.09e-05	0.000753	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.09e-05	0.00075	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCG2—epilepsy syndrome	9.53e-06	0.000657	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2C19—epilepsy syndrome	9.29e-06	0.00064	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP11A1—epilepsy syndrome	9.23e-06	0.000636	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.16e-06	0.000632	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2D6—epilepsy syndrome	8.33e-06	0.000574	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADRA2A—epilepsy syndrome	7.93e-06	0.000547	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—BCHE—epilepsy syndrome	7.9e-06	0.000544	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	7.83e-06	0.00054	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A1—epilepsy syndrome	7.53e-06	0.000519	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCB1—epilepsy syndrome	7.45e-06	0.000514	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TH—epilepsy syndrome	7.43e-06	0.000512	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.31e-06	0.000504	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SRC—epilepsy syndrome	6.49e-06	0.000448	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.32e-06	0.000436	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMOX1—epilepsy syndrome	6.2e-06	0.000427	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAT—epilepsy syndrome	6.11e-06	0.000421	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCB1—epilepsy syndrome	5.95e-06	0.00041	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX1—epilepsy syndrome	5.53e-06	0.000381	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AGT—epilepsy syndrome	4.85e-06	0.000334	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOE—epilepsy syndrome	4.75e-06	0.000327	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—POMC—epilepsy syndrome	4.08e-06	0.000281	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—epilepsy syndrome	4.04e-06	0.000278	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—epilepsy syndrome	3.26e-06	0.000224	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—epilepsy syndrome	1.64e-06	0.000113	CbGpPWpGaD
